A detailed history of Bey Douglas LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bey Douglas LLC holds 1,810 shares of MRK stock, worth $177,470. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,810
Previous 20,601 91.21%
Holding current value
$177,470
Previous $2.64 Billion 99.99%
% of portfolio
0.18%
Previous 2.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $2.09 Million - $2.42 Million
-18,791 Reduced 91.21%
1,810 $205,000
Q2 2024

Jul 19, 2024

BUY
$123.8 - $132.96 $30,207 - $32,442
244 Added 1.2%
20,601 $2.64 Billion
Q1 2024

May 07, 2024

SELL
$113.24 - $131.95 $9,398 - $10,951
-83 Reduced 0.41%
20,357 $2.69 Billion
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $2.05 Million - $2.23 Million
20,440 New
20,440 $2.23 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bey Douglas LLC Portfolio

Follow Bey Douglas LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bey Douglas LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bey Douglas LLC with notifications on news.